GB0324270D0 - Improved control of ES cell self-renewal and lineage specification, and medium therefor - Google Patents

Improved control of ES cell self-renewal and lineage specification, and medium therefor

Info

Publication number
GB0324270D0
GB0324270D0 GB0324270A GB0324270A GB0324270D0 GB 0324270 D0 GB0324270 D0 GB 0324270D0 GB 0324270 A GB0324270 A GB 0324270A GB 0324270 A GB0324270 A GB 0324270A GB 0324270 D0 GB0324270 D0 GB 0324270D0
Authority
GB
United Kingdom
Prior art keywords
renewal
improved control
cell self
medium therefor
lineage specification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0324270A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh filed Critical University of Edinburgh
Priority to GB0324270A priority Critical patent/GB0324270D0/en
Publication of GB0324270D0 publication Critical patent/GB0324270D0/en
Priority to KR1020067007271A priority patent/KR20070030164A/en
Priority to US10/576,358 priority patent/US20070178439A1/en
Priority to PCT/GB2004/004401 priority patent/WO2005038010A2/en
Priority to JP2006534831A priority patent/JP2007508026A/en
Priority to CN 200480030621 priority patent/CN1867666A/en
Priority to EP04791562A priority patent/EP1673444A2/en
Priority to CA002542276A priority patent/CA2542276A1/en
Priority to AU2004281309A priority patent/AU2004281309A1/en
Priority to NZ547105A priority patent/NZ547105A/en
Priority to RU2006116569/13A priority patent/RU2006116569A/en
Priority to TW093131547A priority patent/TW200523367A/en
Priority to IL174388A priority patent/IL174388A0/en
Ceased legal-status Critical Current

Links

GB0324270A 2003-10-16 2003-10-16 Improved control of ES cell self-renewal and lineage specification, and medium therefor Ceased GB0324270D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB0324270A GB0324270D0 (en) 2003-10-16 2003-10-16 Improved control of ES cell self-renewal and lineage specification, and medium therefor
RU2006116569/13A RU2006116569A (en) 2003-10-16 2004-10-15 IMPROVED SELF-SUPPORT CONTROL OF LINEAR SPECIFICATION OF ES-CELLS AND THEIR ENVIRONMENT
EP04791562A EP1673444A2 (en) 2003-10-16 2004-10-15 Control of es cell self-renewal and lineage specification, and medium therefor
US10/576,358 US20070178439A1 (en) 2003-10-16 2004-10-15 Control of es cell self renewal and lineage specification, and medium therefor
PCT/GB2004/004401 WO2005038010A2 (en) 2003-10-16 2004-10-15 Control of es cell self-renewal and lineage specification, and medium therefor
JP2006534831A JP2007508026A (en) 2003-10-16 2004-10-15 Control of self-renewal and lineage specification of ES cells and culture medium therefor
CN 200480030621 CN1867666A (en) 2003-10-16 2004-10-15 Control of es cell self-renewal and lineage specification, and medium therefor
KR1020067007271A KR20070030164A (en) 2003-10-16 2004-10-15 Control of es cell self-renewal and lineage specification, and medium therefor
CA002542276A CA2542276A1 (en) 2003-10-16 2004-10-15 Control of es cell self-renewal and lineage specification, and medium therefor
AU2004281309A AU2004281309A1 (en) 2003-10-16 2004-10-15 Control of ES cell self-renewal and lineage specification, and medium therefor
NZ547105A NZ547105A (en) 2003-10-16 2004-10-15 Control of ES cell self-renewal and lineage specification, and medium therefor
TW093131547A TW200523367A (en) 2003-10-16 2004-10-18 Improved control of ES cell self renewal and lineage specification, and medium therefor
IL174388A IL174388A0 (en) 2003-10-16 2006-03-19 Methods and id gene products for promoting self-renewal of pluripotent stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0324270A GB0324270D0 (en) 2003-10-16 2003-10-16 Improved control of ES cell self-renewal and lineage specification, and medium therefor

Publications (1)

Publication Number Publication Date
GB0324270D0 true GB0324270D0 (en) 2003-11-19

Family

ID=29559425

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0324270A Ceased GB0324270D0 (en) 2003-10-16 2003-10-16 Improved control of ES cell self-renewal and lineage specification, and medium therefor

Country Status (2)

Country Link
CN (1) CN1867666A (en)
GB (1) GB0324270D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0820210A2 (en) * 2007-11-15 2017-05-09 Clanotech Ab compound, pharmaceutical composition, use of a compound, and method of therapeutic treatment of a mammal.
WO2012122318A2 (en) * 2011-03-07 2012-09-13 Massachusetts Institute Of Technology Methods for transfecting cells with nucleic acids
CN108070566A (en) * 2015-08-05 2018-05-25 中国医学科学院基础医学研究所 The stem cell screening model of sitaxsentan sodium object and application

Also Published As

Publication number Publication date
CN1867666A (en) 2006-11-22

Similar Documents

Publication Publication Date Title
EP1562636A4 (en) Mesenchymal stem cells and methods of use thereof
PT2457999T (en) Culture medium for pluripotent stem cells
AU2003217350A1 (en) Proliferated cell lines and uses thereof
EP1488816A4 (en) Closed cell culture system
AU2003285172A8 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
HK1090086A1 (en) Modulation of stem and progenitor cell differentiation, assays, and uses thereof
HK1207883A1 (en) Cell culture method and utilization of the same
EP1644009A4 (en) Compositions and methods for increasing telomerase activity
AU2003260351A8 (en) Cell culture insert
AU2003290432A8 (en) T cell activating gene
EP1668125A4 (en) Modified enzymes, methods to produce modified enzymes and uses thereof
EP1689377A4 (en) Stem cell culture medium and method of using said medium and the cells
EP1557461A4 (en) Composition for culturing multipotent stem cells and utilization of the same
AU2003246130A8 (en) Heat-storage material, composition therefor, and uses of these
IL165969A0 (en) Medium for culturing aurologous human progenitor stem cells and applications thereof
EP1650301A4 (en) Gene imparting redifferentiation ability of plant and utilization of the same
AU2003287521A8 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
GB0324270D0 (en) Improved control of ES cell self-renewal and lineage specification, and medium therefor
WO2004003152A3 (en) Sos1 inhibitors
EP1788089A4 (en) Sequence of themotolerant l-rhamnose isomerase gene and use of the same
EP1496122A4 (en) Novel meloidogyne-resistance gene and utilization thereof
GB0324378D0 (en) Improved control of ES cell self-renewal and lineage specification,and medium therefor
GB0325007D0 (en) Improved control of ES cell self-renewal and lineage specification, and medium therefor
AU2002217911A1 (en) Basal cell carcinoma cultures, methods related thereto and their use
AU2003225642A1 (en) Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)